Lauder family pledges $200M to its Alzheimer’s research work -
NEW YORK — The sons of cosmetics giant Estée Lauder, along with her four grandchildren, pledged $200 million Tuesday to the Alzheimer’s Drug Discovery Foundation, a nonprofit the family founded to support research into finding a cure for the disease.
Starting with a $100 million gift from their mother, the Lauder sons chose to invest in early research of potential treatments using what they called “venture philanthropy,” meaning any returns on their investments were put toward future research. The family also pledges to cover the organization’s expenses so all outside donations go entirely to funding research, Roithmayr said.
The FDA has approved two drugs that target the buildup of amyloid, though the 2021 approval of Biogen’s Aduhelm garnered controversy after the agency overruled its own independent scientific advisers. Legembi, a second drug, approved in January, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s by targeting the disease’s underlying biology.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Euler Says All 'Recoverable Funds' Stolen in $200M Hack Have Been ReturnedThe wild eulerfinance hack has come full circle, with the lending protocol tweeting that the culprit has now returned all “recoverable funds.” sndr_krisztian reports
Read more »
Bakkt completes $200M acquisition of Apex CryptoBakkt was one of the most successful crypto SPACs, forming partnerships with Google and Mastercard before the advent of the bear market.
Read more »
Exclusive: US to build $300 mln database to fuel Alzheimer's researchThe U.S. National Institute on Aging (NIA) is funding a 6-year, up to $300 million project to build a massive Alzheimer's research database that can track the health of Americans for decades and enable researchers to gain new insights on the brain-wasting disease.
Read more »
Painkiller Paradox: 60 Years of Research, But Do They Really Work for Back Pain?Doctors and patients are advised to take a cautious approach to the use of analgesics. Despite nearly 60 years of research, there is still a lack of high certainty evidence on the effectiveness and safety of commonly used painkillers (analgesics) for short bouts of low back pain, finds an analysis
Read more »
Gen Z and Boomers don't agree with millennials on 'work wife' excuseFor years, the idea of a 'work spouse,' a colleague one feels particularly close to given the nature of their work or unique roles, has helped many get through long days at the office. One age group, however, feels it might be time for the idea to go:
Read more »
What Sugar Can Do to Your BrainMost of us have heard that excess sugar is bad for our health—or even that we should avoid it altogether. But the truth is a bit more complicated. Here's what the research can tell us, writes austinperlmd
Read more »